A systematic review of biomarkers for disease progression in Alzheimer's disease - Wikidata - awgldk - TriplyDB

A systematic review of biomarkers for disease progression in Alzheimer's disease

A systematic review of biomarkers for disease progression in Alzheimer's disease

http://www.wikidata.org/entity/Q28539868

about

A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team Structural Neuroimaging of the Medial Temporal Lobe in Alzheimer's Disease Clinical Trials.Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's disease Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.Vectorized nanodelivery systems for ischemic stroke: a concept and a need.The usual suspects: why techno-fixing dementia is flawed.Recent Advances in the Analysis of Complex Glycoproteins.Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products.A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.Feasibility of the Medial Temporal lobe Atrophy index (MTAi) and derived methods for measuring atrophy of the medial temporal lobe A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.

P2860

Q27311651-C0058C16-D6D4-43DE-AF03-D2C5687C602A Q28595520-F8118FEE-400F-405B-A469-2BB4FFFC2C4E Q30996733-5AB18778-F74C-479E-8D99-B73F440EF0CB Q34039695-28AA6ECD-9944-4A3A-B8CB-89B2F3164644 Q35843380-62862F09-38DF-46D6-8A36-E88062FD5C57 Q38597149-D39A399A-28D4-4946-9891-AA6B28C77416 Q38731765-0F34F3DE-7A34-4C7D-8A15-F2614E3874B7 Q38796871-237CC61E-3F0D-444E-939E-498EB917BE16 Q39096219-D40A1AB7-B3CC-4622-9C48-327F6FE38F10 Q39386254-FEB90DFB-6A34-4016-9B10-697472900A45 Q40101067-19BE7BBA-FDBA-4929-896C-95EA5DB251E1 Q40777128-4B9ECD06-F19D-4CFF-9FAE-3EA9676C8A40 Q41911936-6F6BB70F-B5ED-4213-AF66-BA954D45DBA3 Q52721984-26C62639-76FE-4E31-B594-AB2E290F7080

P2860

A systematic review of biomarkers for disease progression in Alzheimer's disease

http://www.wikidata.org/entity/Q28539868

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A systematic review of biomarkers for disease progression in Alzheimer's disease

@ast

A systematic review of biomarkers for disease progression in Alzheimer's disease

@en

A systematic review of biomarkers for disease progression in Alzheimer's disease

@nl

type

label

A systematic review of biomarkers for disease progression in Alzheimer's disease

@ast

A systematic review of biomarkers for disease progression in Alzheimer's disease

@en

A systematic review of biomarkers for disease progression in Alzheimer's disease

@nl

prefLabel

A systematic review of biomarkers for disease progression in Alzheimer's disease

@ast

A systematic review of biomarkers for disease progression in Alzheimer's disease

@en

A systematic review of biomarkers for disease progression in Alzheimer's disease

@nl

P1433

Q28539868-E65B007D-D173-4E00-A134-195B9261AF76

P1476

Q28539868-F8E65FC2-2BD0-4A09-A62E-EF1D20B3E6D1

P2093

Q28539868-12E5A403-3F83-4C87-B9E8-71BBDBEC3254

Q28539868-2C1683CC-D049-4E95-9190-CC100500347D

Q28539868-45F8FA52-ED2C-48BC-82EB-17CB1D9D929C

Q28539868-5F0D5292-626B-4DEB-B3C4-0E4335D81E89

Q28539868-67D8B790-C542-494F-BBD3-EF01BA6C4EAD

P275

Q28539868-47911187-49CA-4A66-93A9-C4E3567076E3

P2860

Q28539868-07F7DF44-53DB-42DE-88D1-641B3B767196

Q28539868-11D00149-BC5A-4CE4-A11D-704A675AF0B2

Q28539868-13ED49B1-2C8B-4365-97A9-CA0E81E35AD5

Q28539868-18186620-4827-443A-999E-1FEB59DDE4E3

Q28539868-1CDC5859-6B5E-4CAF-9A49-00190EE04AA6

Q28539868-1F820C99-062D-4060-801C-BAC8E69C7F86

Q28539868-2D4B8A74-4153-462C-8D8F-EE26F089E7BE

Q28539868-31209313-66BF-41B9-930C-5F02E9BEB7CC

Q28539868-36AAC544-9C24-4C46-B589-C8FA059BEEB7

Q28539868-4759D96A-4F62-4523-9C33-BC9100EB41D4

P304

Q28539868-1BB1B769-2F9C-41E3-9C7C-09801EF8B9DB

P31

Q28539868-848796DA-61DB-4453-B620-156E0FC14C47

Q28539868-ABCC6A2E-40CA-442F-A940-838A39B7F2E3

Q28539868-C4251EBD-F437-41E5-8E0A-EF4A58C8121B

P3181

Q28539868-CEB87B8E-54D3-495D-951B-677C779C6229

P356

Q28539868-312A7138-DB0A-4DDF-90FB-71404ACAC99A

P407

Q28539868-949E0FAE-E068-42D9-B0FD-E53882132440

P433

Q28539868-52567F0E-711D-4B1B-B316-5A96999ECC04

P478

Q28539868-AEFAF9F1-B5DE-4215-8895-3AA1743F858C

P50

Q28539868-DE36959E-CA80-47CC-876A-F301BB2BC951

P5008

Q28539868-B42158FF-4F00-4F58-AEEA-B39FC5532559

P577

Q28539868-303AAA5B-0141-4261-AE58-BA5D6CFB5D50

P698

Q28539868-29D5AFC4-A223-4A77-9359-5FA2D2385A25

P921

Q28539868-26788214-6D06-4BBA-BAE6-781579F8C0CB

Q28539868-89824CDE-532B-4A03-B0C0-4F6FC74A81EE

P932

Q28539868-0C497BE8-9A71-4A90-9E8E-B0B16A7643B2

P3181

P356

JOURNAL.PONE.0088854

P1433

P1476

A systematic review of biomarkers for disease progression in Alzheimer's disease

@en

P2093

Carl E Counsell

http://www.w3.org/2001/XMLSchema#string

David E Wright

http://www.w3.org/2001/XMLSchema#string

David J M McGhee

http://www.w3.org/2001/XMLSchema#string

John P Zajicek

http://www.w3.org/2001/XMLSchema#string

Paul A Thompson

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Statistics review 7: Correlation and regression

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

A systematic review of biomarkers for disease progression in Parkinson's disease

Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.

Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.

Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.

Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations.

P304

e88854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

717684

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0088854

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Craig W Ritchie

P5008

P577

2014-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24558437

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3928315

http://www.w3.org/2001/XMLSchema#string